Randomized Trial of Biolimus DCB for In-Stent Restenosis
Robert A. Byrne(Mater Private Hospital), Fernándo Alfonso(Hospital Universitario de La Princesa), Jochen Wöhrle, Himanshu Rai(Deutsches Herzzentrum München), Seán Fitzgerald(Discovery Laboratories (United States)), Antonio Fernández‐Ortíz(Hospital Clínico San Carlos), Rory Durand, Peter O’Kane(Royal Bournemouth Hospital), Giulio Stefanini(Humanitas University), Darren Mylotte(University Hospital Galway), Ralph Töelg(Segeberger Kliniken), Joo‐Yong Hahn(Samsung Medical Center), Marie‐Claude Morice(Institut Cardiovasculaire Paris Sud), Jasper Trevelyan(Worcestershire Royal Hospital), Manel Sabaté(Hospital Clínico San Carlos), Franz X. Kleber(Wittenberg University), Samuel Copt
Cited by 21
Related Papers
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
|The Lancet|2007|1.4k
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2022|566